摘要
目的:探讨青黛跨膜吸收转运机制。方法:采用Caco-2细胞模型,进行双向转运实验,说明药物转运方式,并比较两种青黛区别,最后考察不同浓度的P-gp、MRP和CYP3A4抑制剂维拉帕米、丙磺舒和酮康唑对青黛分散片与原剂型有效成分的转运量的影响。结果:固体分散技术可以促进青黛有效成分的跨膜转运,该转运为被动转运过程,转运吸收不受P-gp、MRP和CYP3A4影响。结论:固体分散技术可通过青黛溶解度促进其有效成分的吸收。
Objective: To explore the absorption mechanism of Qingdai. Method: Two-way transport experiments were conducted using Caco-2 cell model to explore drug transport way, and compare the difference between two kinds of Qingdai. Then, the influence of different concentrations of P-gp, MRP and CYP3A4 inhibitor verapamil, probenecid and ketoconazole on the transport of effective components of Qingdai dispersion tablets and the original formulation were investigated. Result: Solid dispersion technology can promote the transmembrane transport of effective components of Qingdai. The transport was passive transport which was not affected by P-gp, MRP and CYP3A4. Conclusion: Solid dispersion technology can promote the absorption of active ingredients of Qingdaiby increasing the solubility.
引文
[1]马博,孙桂波,杨志宏,等.肠上皮细胞模型不同培养条件的优化及适应性研究[J].中国实验方剂学杂志,2011,17(11):205
[2]闵志强,叶英杰,张廷模,等.青黛不宜入汤剂的考证[J].四川中医,2010,28(1):52-54
[3]叶英杰,闵志强,杨明,等.青黛分散片制备工艺研究[J].中药药理与临床,2010,1(2):29-31
[4]闵志强.青黛配方分散片研究[D].博士学位论文,成都中医药大学,2010年
[5]闵志强,张廷模.一种青黛饮片及其制备方法[P].专利号:ZL2010 1 0551085.4
[6]闵志强,陈科,李亚丽,等.青黛配方分散片对四氯化碳致小鼠急性肝损伤的保护作用及大鼠原位灌注试验[J].中药药理与临床,2010,26(4):38-40